title: Promising new treatment schedule for gefitinib responders after severe hepatotoxicity with daily administration.
authors.forename: Nobuhiko
authors.initials: N
authors.lastname: Seki
authors.forename: Kazutsugu
authors.initials: K
authors.lastname: Uematsu
authors.forename: Reishi
authors.initials: R
authors.lastname: Shibakuki
authors.forename: Kenji
authors.initials: K
authors.lastname: Eguchi
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D056486:Chemical and Drug Induced Liver Injury; D004334:Drug Administration Schedule; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000502:physiology; D008175:Lung Neoplasms / Q000188:drug therapy; D008875:Middle Aged; D011799:Quinazolines / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib